top of page

Nasal Vaccine, New Solution For Global Health

Published a paper on rice-based oral Vaccine "MucoRice" by our founder.

HanaVax
May 11, 2022
0 min read

Recent Posts

Shionogi and HanaVax Enter into a License Agreement for COVID-19 Vaccine Development

Shionogi and HanaVax Enter into a License Agreement for COVID-19 Vaccine Development

"MucoRice" a rice-based oral vaccine was introduced in RUPTLY.

"MucoRice" a rice-based oral vaccine was introduced in RUPTLY.

Published a paper on rice-based oral vaccine "MucoRice" by our founder.

Published a paper on rice-based oral vaccine "MucoRice" by our founder.

Comentarios

bottom of page